RBC Capital on Bausch & Lomb Corp. (BLCO): 'Rx DED momentum drives estimates higher'

October 8, 2026 8:04 AM

RBC Capital analyst Douglas Miehm reiterated an Outperform rating and $21.00 price target on Bausch & Lomb Corp. (NYSE: BLCO).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found